Skip to content
Disclosery

QVIDTVM Management LLC

Follow

13F filer, CIK 1912226, THE WOODLANDS, TX

QVIDTVM Management LLC reported $113,112,251 across 8 holdings for the quarter ended 2025-03-31, in a 13F-HR filed 2025-05-12.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001912226-25-000003

Period
2025-03-31
Reported value
$113M
Holdings
8
Top 10 weight
100%
New
1
Sold out
1

Largest buys vs the previous quarter

SecurityShares changeApprox. value
COTYnew+1,605,020$8.78M
BIOadded+7,253$1.77M
ZGNadded+41,343$306K
RTOadded+7,500$172K
XRAYadded+5,000$74.7K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
WABreduced-26,333-$4.78M
SOLVreduced-48,350-$3.68M
SINGULAR GENOMICS SYSTEMS INexited-83,671-$1.63M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2025

Share positions as resolved from 13F-HR 0001912226-25-000003, largest first. % of portfolio is the value over $113,112,251, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
SOLVSOLVENTUM CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 497,276 shares; 2024Q4: 562,276 shares; 2025Q1: 513,926 shares 513,926$39.1M34.55%-48,350Timeline
BIOBIO RAD LABS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 125,938 shares; 2024Q4: 118,947 shares; 2025Q1: 126,200 shares 126,200$30.7M27.17%+7,253Timeline
RTORENTOKIL INITIAL PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 750,176 shares; 2024Q4: 649,176 shares; 2025Q1: 656,676 shares 656,676$15M13.29%+7,500Timeline
COTYCOTY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 1,605,020 shares 1,605,020$8.78M7.76%newTimeline
XRAYDENTSPLY SIRONA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 458,866 shares; 2024Q4: 458,866 shares; 2025Q1: 463,866 shares 463,866$6.93M6.13%+5,000Timeline
BRCCBRC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,219,929 shares; 2024Q4: 3,278,634 shares; 2025Q1: 3,301,681 shares 3,301,681$6.9M6.1%+23,047Timeline
ZGNERMENEGILDO ZEGNA N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 295,562 shares; 2024Q4: 378,786 shares; 2025Q1: 420,129 shares 420,129$3.11M2.75%+41,343Timeline
WABWABTECQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 108,475 shares; 2024Q4: 40,334 shares; 2025Q1: 14,001 shares 14,001$2.54M2.24%-26,333Timeline

Sold out in Q1 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
SINGULAR GENOMICS SYSTEMS INSINGULAR GENOMICS SYSTEMS IN83,671$1.63Mshares

How Q1 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001912226-25-000003 base2025-05-12acceptance time not in the bulk data set